Skip to the page

Data / Form D filings / Med Trans EB-5 Fund LLC

Med Trans EB-5 Fund LLC: Form D filing

Med Trans EB-5 Fund LLC, an investing company in New York, NY, filed a Form D with the SEC in 2024. The latest, on February 28, 2024, reports $8 million sold of a $8 million offering to 16 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
232 MADISON AVENUE, SUITE 1001, New York, NY, 10016
Phone
(212) 233-7473
Industry
Investing
Entity type
Limited Liability Company
Incorporated in
New York
Revenue range
$5,000,001 - $25,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1766614

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 28, 2024New notice$8,000,000$8,000,00016Oct 26, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Rebecca S SinghExecutive Officer
Mehreen ShahExecutive Officer

Other investing companies in New York that filed recently

Every Form D from the week of Feb 26, 2024 · All recent filings in New York · All recent Investing filings

Read from SEC EDGAR. Amount sold is what Med Trans EB-5 Fund LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.